Literature DB >> 18215473

Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time.

C Hendricks Brown1, Wei Wang, Sheppard G Kellam, Bengt O Muthén, Hanno Petras, Peter Toyinbo, Jeanne Poduska, Nicholas Ialongo, Peter A Wyman, Patricia Chamberlain, Zili Sloboda, David P MacKinnon, Amy Windham.   

Abstract

Randomized field trials provide unique opportunities to examine the effectiveness of an intervention in real world settings and to test and extend both theory of etiology and theory of intervention. These trials are designed not only to test for overall intervention impact but also to examine how impact varies as a function of individual level characteristics, context, and across time. Examination of such variation in impact requires analytical methods that take into account the trial's multiple nested structure and the evolving changes in outcomes over time. The models that we describe here merge multilevel modeling with growth modeling, allowing for variation in impact to be represented through discrete mixtures--growth mixture models--and nonparametric smooth functions--generalized additive mixed models. These methods are part of an emerging class of multilevel growth mixture models, and we illustrate these with models that examine overall impact and variation in impact. In this paper, we define intent-to-treat analyses in group-randomized multilevel field trials and discuss appropriate ways to identify, examine, and test for variation in impact without inflating the Type I error rate. We describe how to make causal inferences more robust to misspecification of covariates in such analyses and how to summarize and present these interactive intervention effects clearly. Practical strategies for reducing model complexity, checking model fit, and handling missing data are discussed using six randomized field trials to show how these methods may be used across trials randomized at different levels.

Entities:  

Mesh:

Year:  2008        PMID: 18215473      PMCID: PMC2560173          DOI: 10.1016/j.drugalcdep.2007.11.013

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  78 in total

1.  Multilevel mediation modeling in group-based intervention studies.

Authors:  J L Krull; D P MacKinnon
Journal:  Eval Rev       Date:  1999-08

2.  How many imputations are really needed? Some practical clarifications of multiple imputation theory.

Authors:  John W Graham; Allison E Olchowski; Tamika D Gilreath
Journal:  Prev Sci       Date:  2007-06-05

3.  Developmental epidemiological courses leading to antisocial personality disorder and violent and criminal behavior: effects by young adulthood of a universal preventive intervention in first- and second-grade classrooms.

Authors:  Hanno Petras; Sheppard G Kellam; C Hendricks Brown; Bengt O Muthén; Nicholas S Ialongo; Jeanne M Poduska
Journal:  Drug Alcohol Depend       Date:  2008-02-19       Impact factor: 4.492

Review 4.  Clinical trials in psychiatry: should protocol deviation censor patient data?

Authors:  P W Lavori
Journal:  Neuropsychopharmacology       Date:  1992-01       Impact factor: 7.853

Review 5.  Program integrity in primary and early secondary prevention: are implementation effects out of control?

Authors:  A V Dane; B H Schneider
Journal:  Clin Psychol Rev       Date:  1998-01

6.  Analyzing preventive trials with generalized additive models.

Authors:  C H Brown
Journal:  Am J Community Psychol       Date:  1993-10

7.  Six-year follow-up of preventive interventions for children of divorce: a randomized controlled trial.

Authors:  Sharlene A Wolchik; Irwin N Sandler; Roger E Millsap; Brett A Plummer; Shannon M Greene; Edward R Anderson; Spring R Dawson-McClure; Kathleen Hipke; Rachel A Haine
Journal:  JAMA       Date:  2002-10-16       Impact factor: 56.272

8.  Theory-based screening for prevention: focusing on mediating processes in children of divorce.

Authors:  D R Pillow; I N Sandler; S L Braver; S A Wolchik; J C Gersten
Journal:  Am J Community Psychol       Date:  1991-12

9.  Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.

Authors:  James M Swanson; Stephen P Hinshaw; L Eugene Arnold; Robert D Gibbons; Sue Marcus; Kwan Hur; Peter S Jensen; Benedetto Vitiello; Howard B Abikoff; Laurence L Greenhill; Lily Hechtman; William E Pelham; Karen C Wells; C Keith Conners; John S March; Glen R Elliott; Jeffery N Epstein; Kimberly Hoagwood; Betsy Hoza; Brooke S G Molina; Jeffrey H Newcorn; Joanne B Severe; Timothy Wigal
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2007-08       Impact factor: 8.829

10.  Randomized trial of a gatekeeper program for suicide prevention: 1-year impact on secondary school staff.

Authors:  Peter A Wyman; C Hendricks Brown; Jeff Inman; Wendi Cross; Karen Schmeelk-Cone; Jing Guo; Juan B Pena
Journal:  J Consult Clin Psychol       Date:  2008-02
View more
  92 in total

1.  Self-Efficacy About Sexual Risk/Protective Behaviors: Intervention Impact Trajectories Among American Indian Youth.

Authors:  Christina M Mitchell; Carol E Kaufman; Nancy Rumbaugh Whitesell; Janette Beals; Ellen M Keane
Journal:  J Res Adolesc       Date:  2017-03-22

2.  Partnerships for the design, conduct, and analysis of effectiveness, and implementation research: experiences of the prevention science and methodology group.

Authors:  C Hendricks Brown; Sheppard G Kellam; Sheila Kaupert; Bengt O Muthén; Wei Wang; Linda K Muthén; Patricia Chamberlain; Craig L PoVey; Rick Cady; Thomas W Valente; Mitsunori Ogihara; Guillermo J Prado; Hilda M Pantin; Carlos G Gallo; José Szapocznik; Sara J Czaja; John W McManus
Journal:  Adm Policy Ment Health       Date:  2012-07

3.  Do the effects of a family intervention on alcohol and drug use vary by nativity status?

Authors:  David Cordova; Shi Huang; Hilda Pantin; Guillermo Prado
Journal:  Psychol Addict Behav       Date:  2011-12-05

4.  Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses.

Authors:  Ralitza Gueorguieva; Craig Mallinckrodt; John H Krystal
Journal:  Arch Gen Psychiatry       Date:  2011-12

5.  An outcome evaluation of the Sources of Strength suicide prevention program delivered by adolescent peer leaders in high schools.

Authors:  Peter A Wyman; C Hendricks Brown; Mark LoMurray; Karen Schmeelk-Cone; Mariya Petrova; Qin Yu; Erin Walsh; Xin Tu; Wei Wang
Journal:  Am J Public Health       Date:  2010-07-15       Impact factor: 9.308

6.  Testing the universality of the effects of the communities that care prevention system for preventing adolescent drug use and delinquency.

Authors:  Sabrina Oesterle; J David Hawkins; Abigail A Fagan; Robert D Abbott; Richard F Catalano
Journal:  Prev Sci       Date:  2010-12

7.  Examining How Context Changes Intervention Impact: The Use of Effect Sizes in Multilevel Mixture Meta-Analysis.

Authors:  C Hendricks Brown; Wei Wang; Irwin Sandler
Journal:  Child Dev Perspect       Date:  2008-11-28

8.  The efficacy of Familias Unidas on drug and alcohol outcomes for Hispanic delinquent youth: main effects and interaction effects by parental stress and social support.

Authors:  Guillermo Prado; David Cordova; Shi Huang; Yannine Estrada; Alexa Rosen; Guadalupe A Bacio; Giselle Leon Jimenez; Hilda Pantin; C Hendricks Brown; Maria-Rosa Velazquez; Juan Villamar; Derek Freitas; Maria I Tapia; Kathryn McCollister
Journal:  Drug Alcohol Depend       Date:  2012-07-07       Impact factor: 4.492

9.  Treatment effectiveness of PMTO for children's behavior problems in Iceland: assessing parenting practices in a randomized controlled trial.

Authors:  Margrét Sigmarsdóttir; David S Degarmo; Marion S Forgatch; Edda Vikar Guðmundsdóttir
Journal:  Scand J Psychol       Date:  2013-12

Review 10.  Adaptive designs for randomized trials in public health.

Authors:  C Hendricks Brown; Thomas R Ten Have; Booil Jo; Getachew Dagne; Peter A Wyman; Bengt Muthén; Robert D Gibbons
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.